A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS - Related Studies

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

This study has been completed.

Study NCT00000644. Last updated on July 29, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Mycobacterium avium-intracellulare Infection
		Mycobacterium Infections

3	More general conditions related to this trial
		Actinomycetales Infections
		Bacterial Infections
		Gram-Positive Bacterial Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mycobacterium Infections, Atypical
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Clarithromycin

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Synthesis Inhibitors
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)
		Abbott